NasdaqGS:AMPHPharmaceuticals
A Fresh Look at Amphastar Pharmaceuticals (AMPH) Valuation After Recent Share Price Stabilisation
Amphastar Pharmaceuticals (AMPH) has quietly bounced about 3% over the past week and roughly 5% over the past month, even as its year to date return remains down sharply.
See our latest analysis for Amphastar Pharmaceuticals.
That recent 1 month share price return of about 5% looks more like a tentative stabilisation than a full trend change. The share price is still down sharply on a year to date basis and the 1 year total shareholder return remains negative, suggesting sentiment is...